Jounce Therapeutics Inc.

NASDAQ: JNCE · Real-Time Price · USD
1.88
0.00 (0.00%)
At close: May 03, 2023, 10:00 PM

Jounce Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-50.92M -101.85M -100.94M -71.44M -60.61M -25.17M -19.98M -43.93M
Depreciation & Amortization
2.09M 2.29M 2.48M 2.63M 2.83M 2.98M 3.11M 3.25M
Stock-Based Compensation
10.27M 10.62M 10.99M 11.48M 11.48M 10.73M 10.27M 9.98M
Other Working Capital
8.46M 2.51M 34.08M 3.03M -7.52M -4.23M -34.6M -5.12M
Other Non-Cash Items
800K -29.29M -29.16M -29.18M -29.34M 720K 484K 251K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
8.88M 1.92M 35.03M 3.4M -7.85M -5.22M -35.16M -7.34M
Operating Cash Flow
-28.88M -116.31M -81.6M -83.11M -83.49M -15.95M -41.28M -37.79M
Capital Expenditures
-919K -821K -671K -321K -372K -286K -201K -202K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-24.93M -63.29M -76.64M -133.94M -130.27M -140.61M -133.71M -87.3M
Sales Maturities Of Investments
109.33M 111.67M 95.28M 81.01M 70.13M 74.33M 80.48M 85.44M
Other Investing Acitivies
n/a -1K -1K -1K -1K n/a n/a n/a
Investing Cash Flow
83.48M 47.57M 17.97M -53.25M -60.51M -66.56M -53.43M -2.07M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a 55.73M 55.73M 55.73M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 491K 560K 498K 92.04M 160.78M 161.06M 161.15M
Financial Cash Flow
442K 491K 560K 498K 92.04M 160.78M 161.06M 161.15M
Net Cash Flow
55.04M -68.25M -63.07M -135.86M -51.96M 78.26M 66.35M 121.28M
Free Cash Flow
-29.8M -117.13M -82.27M -83.43M -83.87M -16.24M -41.48M -38M